Article Text

Download PDFPDF

Myasthenia gravis: Association of British Neurologists’ management guidelines
  1. Jon Sussman1,
  2. Maria E Farrugia2,
  3. Paul Maddison3,
  4. Marguerite Hill4,
  5. M Isabel Leite5,
  6. David Hilton-Jones5
  1. 1Department of Neurology, Greater Manchester Neuroscience Centre, Salford, Greater Manchester, UK
  2. 2Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK
  3. 3Department of Neurology, Nottingham University Hospitals NHS Trust, Queens Medical Centre,Nottingham, Nottinghamshire, UK
  4. 4Department of Neurology, Morriston Hospital, Swansea, Wales, UK
  5. 5Department of Neurology, John Radcliffe Hospital, Oxford, UK
  1. Correspondence to Dr Jon Sussman, Department of Neurology, Greater Manchester Neuroscience Centre, Stott Lane, Salford, Greater Manchester, M6 8HD, UK; Jon.sussman{at}


Myasthenia gravis is an autoimmune disease of the neuromuscular junction for which many therapies were developed before the era of evidence based medicine. The basic principles of treatment are well known, however, patients continue to receive suboptimal treatment as a result of which a myasthenia gravis guidelines group was established under the aegis of The Association of British Neurologists.

These guidelines attempt to steer a path between evidence-based practice where available, and established best practice where evidence is unavailable. Where there is insufficient evidence or a choice of options, the guidelines invite the clinician to seek the opinion of a myasthenia expert. The guidelines support clinicians not just in using the right treatments in the right order, but in optimising the use of well-known therapeutic agents. Clinical practice can be audited against these guidelines.


Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Linked Articles

  • Editors' commentary
    Phil Smith Geraint N Fuller

Other content recommended for you